Journal of Clinical Orthopaedics and Trauma · Oct 1, 2025

Using the Score for Trauma Triage for Geriatric and Middle-aged (STTGMA) to Cluster High-Risk Hip Fracture Patients for Hospice Discharge

By Hammond B, Olson D, Ganta A et al.

BACKGROUND: Hip fracture patients may be hospice candidates if life expectancy is < 6 months. This study evaluates STTGMAHIP FX's ability to identify high-risk hip fracture patients for hospice discharge at emergency room presentation to guide end-of-life care planning. METHODS: A retrospective analysis of a prospectively maintained registry of patients aged ≥55 with low-energy hip fractures (2014-2024) was conducted. Patients were stratified by STTGMAHIP FX percentiles: minimal (≤50th), low (50th-<80th), moderate (80th-<97.5th), and high (≥97.5th). Demographics, injury characteristics, treatment, and outcomes were recorded. The primary outcome was identification of Hospice Discharge Candidates (HDCs), defined as discharge to hospice during the index admission, inpatient mortality >48 h after surgery, or mortality <6 months post-operation. American Society of Anesthesiologists (ASA) score was compared to STTGMAHIP FX for the ability to cluster HDCs using area under receiver operating characteristic (AUROC) curve analysis and a two-proportion Z-test. RESULTS: Among 2777 patients (mean age 81.18 ± 9.80 years), HDC incidence rose with STTGMAHIP FX risk level: 2.9% (minimal risk), 5.9% (low risk), 14.2% (moderate risk), and 29.6% (high risk) (p < 0.05). Only 17.0% of patients classified as ASA 4 were HDCs. Additionally, STTGMAHIP FX demonstrated a slightly better ability to discriminate HDCs compared to ASA, although not statistically significant (0.719 vs 0.683; p = 0.138). However, the STTGMAHIP FX high risk stratification was much more useful in identifying HDCs than ASA (29.6% vs 17.0%; p = 0.013). CONCLUSION: STTGMAHIP FX identifies hospice-eligible hip fracture patients more effectively than ASA. High-risk patients per STTGMAHIP FX demonstrate elevated 6-month mortality and may benefit from early hospice planning at admission.

doi.org/10.1016/j.jcot.2025.103225PubMed 41111982Biomarkers

AgingResearch.News